🇺🇸 FDA
Patent

US 7314615

IκB Kinase-β (IKKβ) binding antibodies and methods of using same

granted A61KA61K38/00

Quick answer

US patent 7314615 (IκB Kinase-β (IKKβ) binding antibodies and methods of using same) held by The Regents of the University of California expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jan 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K38/00